August 2017 – ADDRESS-2 type 1 diabetes

New study to understand the effect of a drug aiming to preserve beta cells

ADDRESS-2 is now supporting a study to understand better the effect of the drug Abatacept on the immune system in new-onset type 1 diabetes, and how it might work to preserve beta cells.

European study to pave the way to new therapies for type 1 diabetes

ADDRESS-2 is now supporting a major European study aiming to improve the understanding of type 1 diabetes and and pave the way to new therapeutic options to prevent and cure the disease.